We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments.
- Authors
Morozzi, Gabriella; Fabbroni, Marta; Bellisai, Francesca; Pucci, Gabriella; Galeazzi, Mauro
- Abstract
Cartilage oligomeric matrix protein (COMP) is a tissue-specific noncollagenous protein that was first detected in the serum and the synovial fluid of patients suffering from rheumatic disorders, such as rheumatoid arthritis, reactive arthritis, juvenile chronic arthritis, and osteoarthritis. In this review, the authors consider serum COMP levels in different diseases and discuss their study of patients with rheumatoid arthritis treated with anti-TNF-alpha, to evaluate whether COMP is able to predict a rapid and sustained clinical response to these drugs. They observe that patients with high COMP levels have a lower ACR 70 response independently of the state of systemic inflammation, and conclude that COMP seems to have a pathogenetic role that is independent of the mechanisms regulating inflammatory processes.
- Publication
Annals of the New York Academy of Sciences, 2007, Vol 1108, p398
- ISSN
0077-8923
- Publication type
Journal Article
- DOI
10.1196/annals.1422.041